Offering Expert Advisory Review means giving employees access to the world’s most advanced cancer knowledge. It can make the difference between standard cancer care and a better outcome.
Employee Makes Request
Upon a cancer diagnosis, the employee makes a request to initiate an Expert Advisory Review. This is the only action the employee needs to take.
AccessHope Opens Case
When the request reaches AccessHope, an experienced nurse opens a case and requests the patient’s medical records. A multidisciplinary team headed by a subspecialist is assigned to review the case.
Expert Team Reviews Case
The expert team reviews the case and the treatment plan and recommends whether an alternate plan should be considered. The team also generates a detailed report including specific suggestions and supporting evidence, sharing these with the local physician and the employee.
Collaboration Between Physicians
Once reviewed, the report becomes the focal point of a doctor-to-doctor consultation between AccessHope and the employee’s local physician. The AccessHope team remains available for consultation support as clinical questions or challenges arise over the course of a patient’s treatment.
Access to Cancer Support Team
Included in our Expert Advisory Review, is access to our team of experienced oncology nurses. The employee or a family member can call or book an appointment to better understand a specific type of cancer, to get assistance preparing for an appointment, or for any other support.
Check out our other offerings:
Accountable Precision Oncology
The most challenging cancer cases are automatically forwarded to AccessHope’s medical team for expert consultation and evaluation.
Visit a Center of Excellence for an in-person confirmation of diagnosis and consultation on the most effective tests, therapies and treatments.
Cancer Support Team
In collaboration with an Expert Advisory Review, experienced oncology nurses will answer questions via call, text or email to provide support on diagnosis, treatments, appointments and more.